Biogen, Inc. (BIIB)

177.08 +0.75 (+0.43%) USD  |  NASDAQ  |  Dec 26, 16:00
177.17 +0.09 (+0.05%) After-Hours: 20:00
More

Biogen Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Eli Lilly & Co. --
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
Stoke Therapeutics, Inc. --